Insulet Corp. (PODD) Misses Q1 EPS by 5c, Offers Guidance

Insulet Corp. (NASDAQ: PODD) reported Q1 EPS of ($0.11), $0.05 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $69.2 million versus the consensus estimate of $68.47 million.

Insulet Corp. sees FY2014 revenue of $295-315 million, versus the consensus of $306.49 million.

Insulet Corp. sees Q2 2014 revenue of $70-74 million, versus the consensus of $73.86 million.

For earnings history and earnings-related data on Insulet Corp. (PODD) click here.

You May Also Be Interested In

• Nvidia pitches Vera CPU to Chinese clients with August delivery target
• Aspire Biopharma to acquire automotive supplier for $30 million
• McGraw Hill (MH) Tops Q1 EPS by 15c, Beats on Revenue; Offers FY26 Revenue Guidance